2013 Archive

November 2013

Type 1 Diabetes Drug Effective In Stopping Beta Cell Destruction -
An experimental drug that has been studied for nearly 20 years continues to show effectiveness in about half of the patients who participated in a recent phase 2 clinical trial.
New Immune Cell Discovery to Impact Autoimmune Diseases -
Mark Anderson, MD, PhD, and his colleagues have discovered a distinctive type of immune cell called an eTAC, which puts a damper on immune responses and could eventually lead to more effective treatments for autoimmune diseases including type 1 diabetes.
Free Diabetes Education Now Available Online Through Coursera -
Coursera, one of the leading providers of MOOCs (or massive open online courses) is now offering a free course on diabetes taught by faculty members from throughout UCSF’s professional schools: Medicine, Nursing, Pharmacy and Dentistry.
Faculty Member Pursues New Cell Messaging Research -
RNA specialist, Michael McManus, PhD, received an NIH grant to explore and enhance our understanding of a recently discovered cell-to-cell messaging process called extracellular (outside the cell) RNA communication -- exRNA.
New Research Institute Supports Physician-Scientist -
Feroz Papa, MD, PhD, was named a 2013 Harrington Scholar-Innovator by the Harrington Discovery Institute’s Scientific Advisory Board from a field of more than 130 applicants from 53 institutions.
Diabetes prevention focus of clinical trials. San Francisco Chronicle, October 30, 2013 -
Four prevention trials are currently under way at dozens of sites around the country, including both Stanford and UCSF.
California Supreme Court Ruling for Schoolchildren with Diabetes -
After years of legal and legislative challenges, the American Diabetes Association and DREDF won their battle to support California students with diabetes.
Bluestone Elected to Institute of Medicine -
Executive Vice Chancellor and Provost Jeffrey Bluestone, PhD, was elected to the Institute of Medicine (IOM), one of the highest honors in the fields of health and medicine.

October 2013

Diabetes Public Health Specialist Recognized -
This month, Dean Schillinger, MD, was awarded the 2013 Public Health Communications Research Award by the American Public Health Association (APHA).
Cell that Dampens Immune Response Identified by UCSF Researchers -
UCSF researchers have indentified a type of immune cell that appears to put a damper on the body's immune response.